JRCT ID: jRCT2080220831
Registered date:26/08/2009
Basic Information
Recruitment status | |
---|---|
Health condition(s) or Problem(s) studied | Prevention of ulcer associated with NSAIDs |
Date of first enrollment | 26/08/2009 |
Target sample size | |
Countries of recruitment | |
Study type | Interventional |
Intervention(s) | investigational material(s) Generic name etc : AG-1749 INN of investigational material : Therapeutic category code : 232 Agents for peptic ulcer Dosage and Administration for Investigational material : Oral administration |
Outcome(s)
Primary Outcome | |
---|---|
Secondary Outcome |
Key inclusion & exclusion criteria
Age minimum | >= 20age old |
---|---|
Age maximum | Not applicable |
Gender | Both |
Include criteria | 1.Patients who have finished the preceding confirmatory anti-ulcer efficacy study 2.Patients who are on oral NSAIDs therapy at the time of consent and who require continued long-term NSAIDs use even after the start of study treatment in this study |
Exclude criteria |
Related Information
Primary Sponsor | Takeda Pharmaceutical Company Limited |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | |
Secondary ID(s) | JapicCTI-090862 |
Contact
Public contact | |
Name | |
Address | https://www.takeda.co.jp/contact/form/en/form/index.html |
Telephone | |
Affiliation | Takeda Pharmaceutical Company Limited |
Scientific contact | |
Name | |
Address | https://www.takeda.co.jp/contact/form/en/form/index.html |
Telephone | |
Affiliation | Takeda Pharmaceutical Company Limited |